Phase I Study of HS-20108 in Participants With Advanced Solid Tumors

NCT06936735 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

502

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumor

Interventions

DRUG: HS-20108 Monotherapy

Sponsor

Hansoh BioMedical R&D Company